OPEN LABEL
Clinical trials for OPEN LABEL explained in plain language.
Never miss a new study
Get alerted when new OPEN LABEL trials appear
Sign up with your email to follow new studies for OPEN LABEL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-stage study tests a new oral drug, FX-909, alone or with another drug (pembrolizumab) in people with advanced solid tumors, including a type of bladder cancer. The main goals are to check safety and find the best dose. About 120 adults will take part, taking daily pill…
Matched conditions: OPEN LABEL
Phase: PHASE1 • Sponsor: Flare Therapeutics Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Fibromyalgia drug tested in elderly: does age matter?
Knowledge-focused OngoingThis study looks at how the fibromyalgia medication TNX-102 SL (taken under the tongue) is processed in the body of older adults (65+) compared to younger adults (18-45). About 50 healthy participants will receive a single dose, and researchers will measure drug levels and safety…
Matched conditions: OPEN LABEL
Phase: PHASE1 • Sponsor: Tonix Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC